Juntendo Medical Journal
Online ISSN : 2188-2126
Print ISSN : 2187-9737
ISSN-L : 2187-9737
Mini Reviews
Synthetic Lethality in the Search for Novel Molecular Targets in Cancer Therapeutics
YUKO MURAKAMI-TONAMI
Author information
JOURNALS OPEN ACCESS

2019 Volume 65 Issue 3 Pages 292-296

Details
Abstract

 Cancer treatment methods based on suppressing the function of a specific target molecule that is mutated or overexpressed are defined as “molecular targeted therapy”. In molecular targeted therapy, the specific targets are identified in the drug discovery and treatment design stages. Many molecular targeted therapy methods are currently used for cancer treatment, and the group of molecular targeted drugs has grown far beyond the classical chemotherapeutic drug family. However, the design of targeted agents for certain molecules such as tumor suppressor genes, which also play a causative role in cancer, is complex. Here, I briefly review the history of molecular targeted drugs and introduce a search using synthetic lethal phenotypes as one method to identify molecular targeted drugs against tumor suppressor gene mutations.

Information related to the author
© 2018 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original source is properly credited.

This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/
Previous article Next article
feedback
Top